Cite
HARVARD Citation
Mohammad, M. et al. (2017). Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction. Platelets. pp. 414-416. [Online].